冠動脈疾患二次予防のための抗菌薬の利益と有害性 Benefits and harms of antibiotics for secondary prevention of coronary heart disease (Cochrane Review Plain language summary) #Cochrane #CochraneJapan https://t.co/nkCLfm5qOL
@aliciad3 @dr_michaelmarks @Medor_mag @TendonGlasgow https://t.co/rTgPi5rVFF "Meta-analyses at 24±6 months follow-up showed that antibiotics (...) increased the risk of all-cause mortality" RCT "assessing the effects (...) especially quinolones, need lon
Sind #Antibiotika für die Sekundärprävention der koronaren #Herzkrankheit nützlich? Dieser neue @CochraneHeart #systematicReview enthält #Evidenz aus 38 Studien mit insgesamt 26.638 Teilnehmern. Zum Review: https://t.co/qvgFWcLXr7 #KHK #Herzerkrankung #Pr
RT @phellinckx: @HaoYin20 @wise_project https://t.co/rTgPi5rVFF But when it comes to trying to find positive effects as opposed to AE -> 24…
RT @phellinckx: @HaoYin20 @wise_project https://t.co/rTgPi5rVFF But when it comes to trying to find positive effects as opposed to AE -> 24…
@HaoYin20 @wise_project https://t.co/rTgPi5rVFF But when it comes to trying to find positive effects as opposed to AE -> 24 month follow up. "Future trials on the safety (..) of quinolones for the secondary prevention in patients with coronary heart dis
RT @CochraneJapan: 冠動脈疾患の二次予防のための抗生物質(マクロライド系またはキノロン系)の効果を見たコクランレビューです。現在のエビデンスでは、冠動脈疾患の二次予防にマクロライド系およびキノロン系薬剤の臨床使用は有害であり支持できないという結論でした。 h…
RT @CochraneJapan: 冠動脈疾患の二次予防のための抗生物質(マクロライド系またはキノロン系)の効果を見たコクランレビューです。現在のエビデンスでは、冠動脈疾患の二次予防にマクロライド系およびキノロン系薬剤の臨床使用は有害であり支持できないという結論でした。 h…
RT @CochraneJapan: 冠動脈疾患の二次予防のための抗生物質(マクロライド系またはキノロン系)の効果を見たコクランレビューです。現在のエビデンスでは、冠動脈疾患の二次予防にマクロライド系およびキノロン系薬剤の臨床使用は有害であり支持できないという結論でした。 h…
クラビットよく使う心外ドクターの机にこっそり置いとこ☺️
冠動脈疾患の二次予防のための抗生物質(マクロライド系またはキノロン系)の効果を見たコクランレビューです。現在のエビデンスでは、冠動脈疾患の二次予防にマクロライド系およびキノロン系薬剤の臨床使用は有害であり支持できないという結論でした。 https://t.co/jVdE9bOblL
RT @cochranecollab: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneH…
RT @cochranecollab: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneH…
RT @cochranecollab: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneH…
RT @cochranecollab: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneH…
RT @cochranecollab: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneH…
What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants. Read it here: https://t.co/lz8NN
RT @CochraneLibrary: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @Cochrane…
RT @CochraneLibrary: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @Cochrane…
What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants. Read it here: https://t.co/h67xi
Read the article here: https://t.co/K9wolmy5Cw 💊 The photo above is "Antibiotic Drugs" by theglobalpanorama and is licensed under CC BY-SA 2.0. #biom4180
RT @air_garcia: Antibiotics for secondary prevention of coronary heart disease Beneficio - riesgo desfavorable para macrólidos y quinolonas…
Antibiotics for secondary prevention of coronary heart disease Beneficio - riesgo desfavorable para macrólidos y quinolonas https://t.co/mVmlZFshT9
RT @Wiley_Health: What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneLib…
What are the benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease? This new @CochraneLibrary @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants. Read it here: h
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/f2ruS37MIF New @CochraneH…
Important negative finding TL:DR version Antibiotics for secondary prevention of CHD are probably harmful Increased: all-cause mortality RR 1.25 (95%CI 1.06-1.48) CVD mortality RR 1.50 (95%CI 1.17-1.91) Sudden cardiac death RR 1.77 (95%CI 1.28-2.44). h
RT @SouthAfricanASP: “Antibiotics for secondary prevention #CHD ⬆️ risk all‐cause & CVS mortality & stroke. Future trials on the safety of…
RT @SouthAfricanASP: “Antibiotics for secondary prevention #CHD ⬆️ risk all‐cause & CVS mortality & stroke. Future trials on the safety of…
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/f2ruS37MIF New @CochraneH…
RT @SouthAfricanASP: “Antibiotics for secondary prevention #CHD ⬆️ risk all‐cause & CVS mortality & stroke. Future trials on the safety of…
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease. New @CochraneHeart systematic review…
Cochrane Database of Systematic Reviews Review - Intervention Antibiotics for secondary prevention of coronary heart disease https://t.co/xc52HJoPJf
“Antibiotics for secondary prevention #CHD ⬆️ risk all‐cause & CVS mortality & stroke. Future trials on the safety of macrolides or quinolones for this indication do not seem ethical.” Hear hear. https://t.co/PoqKJljH0j
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/f2ruS37MIF New @CochraneH…
Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/f2ruS37MIF New @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants. https://t.co/A4B7GgGdU6
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease. New @CochraneHeart systematic review…
RT @CochraneUK: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease. New @CochraneHeart systematic review…
Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease. New @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants: https://t.co/f2ruS37MIF https://t.co/CGimcRy8Jf
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
Antibiotics for secondary prevention of coronary heart disease - Cochrane Database of Systematic review https://t.co/flTx9xxbZh
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
RT @CochraneLibrary: Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @Coc…
Benefits and harms of antibiotics for secondary prevention of coronary #HeartDisease https://t.co/h67xi2ruKR New @CochraneHeart systematic review includes the evidence from 38 trials randomising a total of 26,638 participants.
New NNT→Antibiotics for secondary prevention of coronary heart disease https://t.co/jH089cAC1x